/L) neutrophils. Hospital policy prohibited emergency department (ED) glucometer testing (because of inadequate staff training); therefore, all serum glucose measurements were performed by the laboratory. The patient's initial serum glucose was 1.1 mmol/L. His second level, at 4 hours, was 1.3 mmol/L. Despite these levels, he remained alert and oriented.
Six hours after the patient's arrival at the ED, the attending nurse noted that he appeared diaphoretic and drowsy while he was standing outside the ED, smoking. However, he was able to walk back to his bed independently. He fell asleep, but was easily aroused and remained oriented. At this point his serum glucose was 0.2 mmol/L. The dextrose infusion was increased to D10W at 125 mL/h, and hourly glucose measurements were obtained.
The patient subsequently had 2 more episodes of laboratory hypoglycemia (2.6 mmol/L and 3.2 mmol/L). He was given 50 mL IV boluses of D50W following every hypoglycemic (<3.3 mmol/L) laboratory result.
After approximately 14 hours, his serum glucose stabilized in the normal range and a sliding scale of regular insulin was introduced. Throughout his therapy the patient remained normokalemic and did not receive potassium supplementation. Toxicology screening and free insulin levels were not performed because it was felt they would not contribute to patient management. No additional cognitive testing, beyond the Glasgow Coma Scale, was performed in the ED.
Discussion
This patient exhibited an unusual and exceptional tolerance to hypoglycemia. On 3 occasions he was alert and oriented, with glucose levels of 1.1 mmol/L (twice) and 1.3 mmol/L. With a glucose level of 0.2 mmol/L he was drowsy but oriented.
Symptoms of hypoglycemia usually appear at glucose levels of 2.8 to 3.3 mmol/L.
1 Impaired brain function usually becomes apparent below 2.8 mmol/L,but subtle changes may occur at levels of 3.0-3.3 mmol/L. [1] [2] [3] Some individuals tolerate glucose levels below 2.0 mmol/L without cognitive changes. found that the maximum change in neurologic response occurred 10 to 60 minutes after nadir glucose levels were reached. In addition, recurrent hypoglycemic episodes lead to a form of tolerance, with decreased production of insulin counter-regulatory hormones and reduced sympathetic response to hypoglycemia. 5 This patient had attempted suicide at least once, recently, using insulin. And, based on his history of regular insulin use with poor, infrequent meals and recreational drug and alcohol abuse, he may also have had frequent episodes of hypoglycemia.
Conclusion
This patient's exceptional hypoglycemic tolerance may be explained by genetic predisposition, acquired tolerance and delayed onset of symptoms. Clinical findings may not always reflect serum glucose levels, and "occult" hypoglycemia may be more common than we think.
